3'-Azidothymidine may potently inhibit the biosynthesis of polylactosamine chains on highly glycosylated-CD147 and reduce matrix metalloproteinase-2 expression in SGC-7901 and U251 cells

Xu,Xu; Hu,Yu; Ni,Jianlong; Hu,Shuijun; Jiang,Zhi; Xu,Lan; Liu,Chunliang; Hua,Dong; Wu,Shiliang

doi:10.3892/mmr.2015.3241

3'-Azidothymidine may potently inhibit the biosynthesis of polylactosamine chains on highly glycosylated-CD147 and reduce matrix metalloproteinase-2 expression in SGC-7901 and U251 cells

Authors:
- Xu Xu
- Yu Hu
- Jianlong Ni
- Shuijun Hu
- Zhi Jiang
- Lan Xu
- Chunliang Liu
- Dong Hua
- Shiliang Wu
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, School of Medicine, Soochow University, Suzhou, Jiangsu 215123, P.R. China, The Fourth Affiliated Hospital of Soochow University, Wuxi, Jiangsu 214062, P.R. China
Published online on: January 22, 2015 https://doi.org/10.3892/mmr.2015.3241
Pages: 4713-4719

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alterations to N‑linked glycans are closely associated with cancer progression. Of particular importance in tumor growth and invasion, is the synthesis of complex N‑linked oligosaccharides containing poly‑N‑acetyllactosamine (polylactosamine) chains, which have previously been reported to inhibit 3'‑azidothymidine (AZT). Cluster of differentiation 147 (CD147) is a glycoprotein that carries β1,6‑branched polylactosamine sugars on its N‑glycans. The present study aimed to explore the mechanism by which AZT may affect matrix metalloproteinase‑2 (MMP2) expression and the cell cycle via regulation of the N‑glycans on CD147 in SGC‑7901 and U251 cell lines. Subsequent to treatment with various concentrations of AZT, the N‑glycans of highly glycosylated (HG)‑CD147 were observed to decrease in the two cell lines, and the expression of MMP2 was also significantly decreased. In addition, cell cycle analysis demonstrated that the percentage of the cells in the G1 phase increased in a dose‑dependent manner with AZT treatment, indicating that AZT may inhibit cell proliferation in SGC‑7901 cells. It was suggested that AZT may reduce the biosynthesis of polylactosamine chains on CD147 and reduce MMP2 expression to inhibit cell proliferation in SGC‑7901 and U251 cells. Thus, AZT is suggested to be an antineoplastic drug, which may be effective therapeutically for certain types of cancer through acting on the N‑glycans of HG‑CD147.

View Figures

View References

1	Kato T, Suzuki M, Murata T and Park EY: The effects of N-glycosylation sites and the N-terminal region on the biological function of beta1,3-N-acetylglucosaminyltransferase 2 and its secretion. Biochem Biophys Res Commun. 329:699–705. 2005. View Article : Google Scholar : PubMed/NCBI
2	Narimatsu H: Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. Curr Opin Struct Biol. 16:567–575. 2006. View Article : Google Scholar : PubMed/NCBI
3	Hakomori S: Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA. 99:10231–10233. 2002. View Article : Google Scholar : PubMed/NCBI
4	Saitoh O, Wang WC, Lotan R and Fukuda M: Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 267:5700–5711. 1992.PubMed/NCBI
5	Kinoshita M, Mitsui Y, Kakoi N, Yamada K, Hayakawa T and Kakehi K: Common glycoproteins expressing polylactosamine-type glycans on matched patient primary and metastatic melanoma cells show different glycan profiles. J Proteome Res. 2013.PubMed/NCBI
6	Mitsui Y, Yamada K, Hara S, Kinoshita M, Hayakawa T and Kakehi K: Comparative studies on glycoproteins expressing polylactosamine-type N-glycans in cancer cells. J Pharm Biomed Anal. 70:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
7	Togayachi A, Kozono Y, Ishida H, et al: Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation. Proc Natl Acad Sci USA. 104:15829–15834. 2007. View Article : Google Scholar : PubMed/NCBI
8	Tang W, Chang SB and Hemler ME: Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell. 15:4043–4050. 2004. View Article : Google Scholar : PubMed/NCBI
9	Huang W, Luo WJ, Zhu P, et al: Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem J. 449:437–448. 2013. View Article : Google Scholar
10	Gabison EE, Hoang-Xuan T, Mauviel A and Menashi S: EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 87:361–368. 2005. View Article : Google Scholar : PubMed/NCBI
11	Agrawal SM and Yong VW: The many faces of EMMPRIN - roles in neuroinflammation. Biochim Biophys Acta. 1812:213–219. 2011. View Article : Google Scholar
12	Hall ET, Yan JP, Melançon P and Kuchta RD: 3′-Azido-3′-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity. J Biol Chem. 269:14355–14358. 1994.PubMed/NCBI
13	Steet RA, Melancon P and Kuchta RD: 3′-Azidothymidine potently inhibits the biosynthesis of highly branched N-linked oligosaccharides and poly-N-acetyllactosamine chains in cells. J Biol Chem. 275:26812–26820. 2000.PubMed/NCBI
14	Liu Z, Shen L, Xu L, Sun X, Zhou J and Wu S: Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. Mol Med Rep. 4:497–503. 2011.PubMed/NCBI
15	van den Eijnden DH, Koenderman AH and Schiphorst WE: Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc:N-acetyllactosaminide beta 1 - 3-N-acetylglucos aminyltransferase from Novikoff tumor cell ascites fluid. J Biol Chem. 263:12461–12471. 1988.PubMed/NCBI
16	Ishida H, Togayachi A, Sakai T, et al: A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar
17	Do KY and Cummings RD: 2,6-branched mannose and the regulation of poly-N-acetyllactosamine biosynthesis in N-linked oligosaccharides of Chinese hamster ovary cells. J Biol Chem. 268:22028–22035. 1993.PubMed/NCBI
18	Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56:5309–5318. 1996.PubMed/NCBI
19	Pierce M, Buckhaults P, Chen L and Fregien N: Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J. 14:623–630. 1997. View Article : Google Scholar : PubMed/NCBI
20	Datti A, Orlacchio A, Siminovitch KA and Dennis JW: A coupled assay for UDP-GlcNAc:Gal beta 1-3GalNAc-R beta 1,6-N-acetylglucosaminyltransferase (GlcNAc to GalNAc). Anal Biochem. 206:262–266. 1992. View Article : Google Scholar : PubMed/NCBI
21	Sawada R, Lowe JB and Fukuda M: E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem. 268:12675–12681. 1993.PubMed/NCBI
22	Krishnan V, Bane SM, Kawle PD, Naresh KN and Kalraiya RD: Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis. 22:11–24. 2005. View Article : Google Scholar : PubMed/NCBI
23	Ishida H, Togayachi A, Sakai T, et al: A novel beta1,3-N-acetyl-glucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar
24	Ni J, Jiang Z, Shen L, et al: β3GnT8 regulates the metastatic potential of colorectal carcinoma cells by altering the glycosylation of CD147. Oncol Rep. 31:1795–1801. 2014.PubMed/NCBI
25	Venkatesan B, Valente AJ, Prabhu SD, Shanmugam P, Delafontaine P and Chandrasekar B: EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB and MKK7/JNK/AP-1 signaling. J Mol Cell Cardiol. 49:655–663. 2010. View Article : Google Scholar : PubMed/NCBI
26	Li G, Zhang Y, Qian Y, Zhang H, et al: Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α pathway. Mol Immunol. 53:227–236. 2013. View Article : Google Scholar
27	Sun P, Mu Y and Zhang S: A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1. Tumour Biol. 35:12721–12727. 2014. View Article : Google Scholar : PubMed/NCBI
28	Han YP, Tuan TL, Wu H, Hughes and Garner WL: TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci. 114:131–139. 2001.